Examination of the kinetic mechanism of mitogen-activated protein kinase activated protein kinase-2
John F. Schindler, Joseph B. Monahan(Aclaris Therapeutics (United States)), Suzanne L Bolten, Aaron J Cassely, Heidi M. Morgan, Richard M. Broadus, Mark A. Nagy, Jeffery L Hirsch, Matthew J. Saabye, Robert P. Compton, Robert J. Mourey, Kam F. Fok(Pfizer (United States)), William F. Hood, Michelle A Merwood, Andrew Godbey, Thomas P. Kasten(Monsanto (United States)), Arthur J. Wittwer(Pfizer (United States))
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
July 1, 2002
Cited by 21
Related Papers
Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
|European Journal of Pharmacology|1993|727
Molecular Docking and High-Throughput Screening for Novel Inhibitors of Protein Tyrosine Phosphatase-1B
|Journal of Medicinal Chemistry|2002|467
Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase.
|Proceedings of the National Academy of Sciences|1994|243
Analysis of the phosphofructokinase subunits and isoenzymes in human tissues
|Biochemical Journal|1988|157
α2-Macroglobulin Is a Novel Substrate for ADAMTS-4 and ADAMTS-5 and Represents an Endogenous Inhibitor of These Enzymes
|Journal of Biological Chemistry|2004|141